Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2026-02-12 @ 6:29 AM
Study NCT ID:
NCT03986034
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2019-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
190111
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None